Join us on 12-15-2022 for a live seminar about RNA SEQ

Click Here

High Efficiency CAR Discovery & Screening

Are you looking to begin a discovery campaign sometime in the next 6 months?(Required)

Access the webinar recording

Thanks for your interest in our recent High Efficiency CAR Discovery & Screening webinar. Please fill out your contact information, and we will email you shortly with a link and passcode to access the recording.

Our approach

Chimeric antigen receptor cell therapy (CAR-T, CAR-NK, etc.) is a promising therapeutic modality, but functional screening is a bottleneck for traditional two-step CAR-T discovery process of antibody binder discovery and CAR-T functional engineering. In this webinar, scientists at Alloy showcase their unique CAR discovery workflow that incorporates human antibody identification and characterization, mRNA-based CAR construct generation, and in vitro and in vivo functional screening. Learn from the discovery scientists that helm this process and help cell therapy companies and discovery teams identify functional chimeric antigen receptors three months faster than conventional approaches.

Webinar Speakers

Dongxing Zha

CEO of Keyway TCR Discovery at Alloy

Beau Carson

Senior Director, Head of Translational Medicine at Alloy

Accept Privacy Settings Here
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please read and Privacy Policy
Consent to display content from - Youtube
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound